Skip to Main Content

+1 (508) 881-6771

Human Tissue Models

Mattek’s lab-grown human epithelial tissues are living, metabolically active 3D tissue models that provide greater insight into clinical outcomes.

EpiAlveolar™

Product Overview

Primary Cells Media

Mattek’s decades-long expertise in cell isolation and expansion has created a large and diverse inventory of primary cells from native donor tissue. 3D-certified cells for elevated biological research.

Cultureware

Mattek Dishes have set the benchmark for cell culture and imaging excellence for nearly 40 years. Experience the optical clarity and precision of glass in a Petri dish.

Visikol Products

We offer several reagents and supporting materials that provide researchers with an unprecedented view of tissues for enhanced characterization.

News & Resources

December 11, 2015

DRUG PERMEABILITY ACROSS BOVINE RESPIRATORY TISSUES COMPARED TO A HUMAN TRACHEO/BRONCHIAL CELL CULTURE (EPIAIRWAY™ SYSTEM).

The past three decades have seen the emergence of the nasal mucosa as a viable alternative route...

December 11, 2015

DAS181, A SIALIDASE FUSION PROTEIN, PROTECTS HUMAN AIRWAY EPITHELIUM AGAINST INFLUENZA VIRUS INFECTION: AN IN VITRO PHARMACODYNAMIC ANALYSIS.

This study by researchers at NexBio and the University of Hong Kong demonstrated that Mattek’s EpiAirway in...

December 11, 2015

RECONSTRUCTION OF NEW ORGANOTYPIC 3D HUMAN SMALL INTESTINE TISSUE MODEL FOR DRUG SAFETY AND TOXICITY.

The epithelial lining of the gastrointestinal (GI) tract is a gatekeeper for entry of orally ingested nutrients...

December 11, 2015

PERMEATION OF WIN 55,212-2, A POTENT CANNABINOID RECEPTOR AGONIST, ACROSS HUMAN TRACHEO-BRONCHIAL TISSUE (EPIAIRWAY™) IN VITRO AND RAT NASAL EPITHELIUM IN VIVO.

R-(+)-WIN 55,212-2 is prone to hepatic first-pass metabolism and variable bioavailability following oral administration. The aim of...

December 11, 2015

THE EFFICACY OF ECHINACEA IN A 3-D TISSUE MODEL OF HUMAN AIRWAY EPITHELIUM.

This study by researchers at the University of British Columbia and A. Vogel Bioforce AG demonstrated that...